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The immune response to many viral infections is characterized by the induction 
of a  response from both the cytolytic and helper/amplifier T  lymphocyte (Th) 
subsets. Classically described antiviral CTL are restricted by class I  MHC gene 
products in their recognition of viral and other foreign antigens, while Th are 
restricted by MHC class II gene products (1, 2). These two T  lymphocyte subsets 
are also believed to differ in their effector functions (2), cell surface phenotypes 
(3), and requirements for foreign antigen recognition (4, 5). 
Although alloreactive  CTL  responses  to  MHC  class  II  antigens are  well- 
documented (6-11),  T  lymphocytes that exhibit cytolytic activity and are  re- 
stricted by MHC class  II  molecules in nominal antigen recognition have only 
recently been appreciated as a distinct T  lymphocyte subpopulation. They were 
first described in the recognition of hapten-modified cells (12),  and later in the 
recognition of virus-infected cells in the human (13-15). Since then, there have 
been many additional reports of foreign antigen-specific, class II-restricted CTL 
(16-18). 
We have recently described a  series of cloned T  lymphocytes derived from 
mice infected with type A  influenza virus that are restricted in influenza viral 
antigen recognition by H-2I  region gene products and,  like conventional H- 
2K/D-restricted CTL, specifically and directly lyse virus-infected target cells in 
vitro in an  MHC-restricted fashion (19).  These class  II-restricted,  influenza- 
specific CTL, along with a  panel of influenza-specific, class  I-restricted CTL, 
provided us with a  unique opportunity to examine the recognition of influenza 
viral antigens expressed on infected ceils by cloned T  lymphocyte populations 
with identical functional activities but different MHC class  restrictions. In this 
study we examine the role of viral antigen presentation in target cell recognition 
by  these  two  CTL  types.  We  have  observed  that  like  conventional class  I- 
restricted CTL, class  II-restricted CTL lysed infected histocompatible target 
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cells, yet these H-2I region-restricted CTL also recognized target cells exposed 
to noninfectious virion preparations or purified hemagglutinin  (HA) ~ polypep- 
tide. In addition, target cell sensitization for recognition by these H-2I region- 
restricted CTL was inhibited by the lysosomotrophic agent chloroquine, but was 
unaffected by inhibition  of viral  protein  synthesis  in  the  target  cells.  Finally, 
unlike H-2K/D region-restricted CTL, the H-2I region-restricted CTL did not 
recognize the  protein  product of the  influenza  HA  gene  introduced into  the 
target cells using a  recombinant vaccinia virus expression vector. These results 
suggest that potentially important differences may exist in the character of the 
antigenic determinants recognized by the majority of MHC class I- and class II- 
restricted, influenza-specific CTL. The potential implications of these results for 
CTL recognition and antiviral immunity are discussed. 
Materials and Methods 
Animals.  Female CB6F1/J  (BALB/cJ [H-2  d]  X  C57BL/6J  [H-2b]) and  BALB/cByJ 
mice, and male CBA/J (H-2  ~) mice were purchased from the Jackson Laboratory, Bar 
Harbor, ME, and used at 7-14-wk-old. 
Viruses.  Influenza virus strains A[JAP/57 (A/Japan/305/57  [H2N2]), and B/Lee were 
grown in the ailantoic cavity of 10-d-old embryonated chicken eggs and stored as infectious 
allantoic fluid as previously described (20). Purified A/JAP/57 virus (21) at a concentration 
1.67  X  105 hemagglutinating units (HAU)/ml in PBS was subjected to inactivation by 
exposure to UV light, as described elsewhere (22). The inactivated preparation contained 
no residual infectious virus as assayed by methods previously described (19). 
Vaccinia virus (VV),  as an  infected cell sonicate and a  highly purified (2.8  x  101° 
PFU/ml) preparation of vaccinia virus/influenza HA (VV/HA) recombinant (23),  were 
the generous gifts of Dr.  B.  Moss (National  Institutes of Health, Bethesda, MD).  The 
recombinant virus was constructed by inserting into the VV genome a DNA copy of the 
gene encoding influenza virus A/JAP/305/57 (H2) HA. 
Purified HA (80 #g/ml) was  isolated from A/JAP/305/57 virions by Triton X-100 
extraction and ion exchange chromatography. 
Celt Lines.  The  B  cell  lymphoma line  A20-1.11  (24)  (H-2  a) and  the  P815  (H-2  d) 
mastocytoma line were maintained in culture in DME (Gibco Laboratories, Grand Island, 
N¥) supplemented with antibiotics, 1% glutamine, and 10% FCS. 
The L cell (H-2  k) transformant CA36.2.1, transfected with the E k and the E~o genes by 
DNA-mediated gene transfer (25), was kindly provided by Dr. B.  Malissen  (Le Centre 
d'Immunologie, Marseille, France), and was maintained in continuous culture using the 
selective medium HAT supplemented with antibiotics, 10% FCS, and 1% glutamine. This 
line expresses high levels of the transfected gene products as determined by flow cyto- 
fluorometry using specific monoclonal reagents (Lukacher, A., unpublished observations). 
Cloned T Lymphocyte Lines.  All cloned CTL populations were derived from primed 
CTL precursors isolated from the spleens of donor mice immunized >3 wk previously 
with infectious A/JAP/57  virus (3.5  ×  107 infectious virus units per mouse) (20).  The 
CTL clones were isolated and established as previously described (26,  27).  Under the 
cloning conditions used only immune  T  lymphocyte precursors routinely give rise to 
continuous  in  vitro  CTL  clones  (26).  The  influenza type  A-specific,  MHC  class  I- 
restricted  clones  14-1,  14-7,  14-13,  A4,  35-6,  and  36-1  were  maintained  by  weekly 
subculture with fresh A/JAP/57-infected splenocytes of the appropriate haplotype. The 
influenza type A-specific, MHC class lI-restricted clones G1, U-12, D8, V-4, and U-5 
were restimulated weekly with inactivated virus-pulsed splenocytes in media and condi- 
tions otherwise identical to the class I-restricted CTL, as detailed elsewhere (19). These 
1 Abbreviations  used in this paper:  HA, hemagg|utinin; HAU, hemagglutinating units; NP, nucleo- 
protein; VV,  vaccinia virus; VV/HA,  vaccinia virus-A/JAP/57 bemagglutinin gene recombinant 
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class  II-restricted CTL  can  be  driven  to  proliferate  in  response  to  syngeneic,  virus- 
infected splenocytes in the absence of exogenous growth factors (19). 
Assays for Cell-mediated Cytotoxieity.  P815 cells,  A20-1.11  cells, and the L cell  trans- 
fectant CA36.2.1  were used as target cells in S~Cr-release assays, which were carried out 
essentially as described elsewhere (26). Briefly, 5tCr-labeled  target cell groups were washed 
twice  and  treated  either  with  infectious virus,  inactivated  virus,  purified  HA,  or  left 
uninfected  in  serum-free  medium  for  10  min  at  4°C,  then  incubated  1  h  at  37°C. 
Subsequently, groups were washed twice,  and 104 cells were placed in individual wells of 
round-bottom 96-well microtiter plates in a volume of 0.1  ml DME plus 10% FCS. T cell 
clones, 4-6 d after routine subculture, were added in 0.1-ml vol per well. After incubation 
for 6 h  at  37°C and  7%  CO2,  100 t~l supernatant from each well as removed and the 
radioactivity counted. Values for percent specific release represent the mean counts per 
minute of quadruplicate cultures. SEM fell below 5% of the mean values in all instances 
and are omitted. 
For experiments  requiring addition  of emetine,  CA36.2.1  target cells  were washed 
once in medium alone or in medium containing 10  -5 M emetine dihydrochloride (Sigma 
Chemical Co., St.  Louis, MO).  Target cell groups were first virus-infected, then labeled 
with 5~Cr, each in the absence or presence of emetine. After labeling,  cells were washed 
once with or without emetine, and once without emetine. All target groups were diluted 
in medium without emetine before addition to the assay. 
Cytotoxicity Assays  in  the  Presence of Chloroquine.  In  studies  of the  impact  of the 
lysosomotropic agent chloroquine on CTL recognition it was noted that the effect of this 
agent was slowly reversible. Thus, target cells pretreated with chloroquine (5 ×  10  -5 M) 
at the time of exposure to infectious or inactivated virus and subsequently maintained in 
the absence of the agent during the cytotoxicity assay became increasingly susceptible  to 
lysis by class  II-restricted CTL  with  increasing  time  after  removal  of the  drug.  To 
circumvent this  problem  of chloroquine reversibility the  following modifications were 
made when chloroquine was used in the assay: A20-1.11 target cells were first incubated 
with 5mCr, then washed in medium alone or containing 5 ×  10  -5 M chloroquine (Sigma 
Chemical Co.).  Each target group was resuspended in 0.4 ml media alone or containing 
6.25 ×  10  -5 M chloroquine, and 0.1  ml of infectious allantoic fluid,  inactivated virus or 
purified HA in  PBS (30 HAU/5 ×  105 cells), or PBS alone, was added to each group. 
The final chloroquine concentration during infection was thus 5 ×  10  -5 M. After infection, 
cells  were washed twice with or without 5  ×  10  -6  M  chioroquine, and diluted  before 
addition to the assay in medium alone or containing 10  -5 M chloroquine; 1:1 dilution of 
target cells in the assay wells yielded a final chloroquine concentration of 5 ×  10  -6 M. 
Results 
We have recently described the properties of a  panel of cloned CTL that are 
restricted in influenza virus recognition by MHC class II-encoded gene products 
(19).  Most of these clones proliferate in the absence of an exogenous source of 
the growth factor IL-2, express the L3T4 marker, and produce, after antigenic 
stimulation, soluble factors that augment a primary in vitro antibody response to 
SRBC in a  noncognate fashion (19).  These phenotypic properties resemble the 
properties  of T  lymphocytes of the  helper/amplifier  subset.  Since  influenza- 
specific Th can proliferate in  response to noninfectious forms of the influenza 
virion  (28-31),  we  wished  to  determine  whether  the  class  II-restricted  CTL 
could recognize and destroy target cells exposed to noninfectious forms of the 
virus.  Experiment  I  in  Table  I  shows  the  results  of a  standard  ~Cr-release 
cytotoxicity assay  in  which  cells  of the  Ia  + B  lymphoma line  A20-1.11  (H-2  a) 
were infected with A/JAP/57 influenza virus or pulsed with UV light-inactivated 
purified influenza A/JAP/57 virions, then used as target cells for a panel of class 
I- and  class  II-restricted,  anti-influenza  CTL  clones.  As  previously  reported 906  VIRUS  RECOGNITION  BY  K/D  AND  1  REGION-RESTRICTED  T  CELLS 
TABLE  I 
CTL Recognition of Target Cells Sensitized with 
Noninfectious  Influenza Virus 
E/T 
Exp.  Clone  ratio 
Percent specific 5tCr-release* using 
A20-1.11 targets 
Unin-  UV-A/JAP  A/JAP 
fected  pulsed*  infected 
14-1  2:1  01  5  49 
8:1  O  9  65 
14-7  2:1  0  0  49 
8:1  0  0  60 
14-13  2:1  0  0  44 
8:1  0  0  50 
A4  2:1  0  0  49 
8:1  0  0  55 
G1  2:1  0  31  48 
8:1  1  46  65 
U-5  2:1  0  22  34 
8:1  1  34  44 
U-12  2:1  1  29  45 
8:1  0  43  62 
V-4  2:1  0  43  49 
8:1  2  56  67 
2  CA36.2.1  targets 
35-6  2:1  0  1  17 
8:1  2  3  33 
36-1  2:i  0  1  18 
8:1  1  0  40 
GI  2:1  3  20  20 
8:1  9  36  34 
U-12  2:1  0  24  22 
8:1  3  40  38 
* Cloned T  cell lines were examined for cytolytic activity on uninfected, 
infected, or inactivated virus-pulsed, S~Cr-labeled target cells 5-6 d after 
routine subculturing (see Materials and Methods).  104 target cells were 
added per well. Spontaneous 5~Cr-release from A20-1.11  target groups 
was <10%, and from CA36.2.1  target groups <15% over an assay time 
of 6  h. 
* 300  HAU  of purified,  UV  light-inactivated  A/JAP/57  virus per  5  × 
10  ~ cells was used to pulse the A20-1.11 and CA36.2.1  target cells. 
i Values are the means of four replicate wells; SEM were <5%  of mean 
values and are omitted. MORRISON  ET AL. 
TABLE II 
Antigen Dose Dependence of Target Cell Sensitization by Inactivated Influenza Virus 
907 
Percent specific ~Cr-release from CA36.2.1 targets* 
Clone  UV-virus pulsed (HAU/5 x  105 cells)  Exp. 
Uninfected  A/JAP infected 
2,500  1,000  100  l0  l  0.1* 
U-12  4  i  47  52  52  51  42  18  l0 
G1  4  73  88  63  50  27  6  7 
2  D8  15  71  ND  77  62  39  27  28 
Gl  18  76  ND  75  75  70  41  33 
* As in Table I. Spontaneous 5~Cr-release from all target groups was <24% in Exp. 1 and <20% in 
Exp. 2. E/T ratio is 8:1 in Exp. i and 4:1 in Exp. 2. 
:~ Indicates dose of purified, UV light-inactivated A/JAP/57  virus in HAU used to treat 5 ×  105 
target cells. 
As in Table I. 
(19),  both  the  K/D  and  the  I  region-restricted  clones  recognize  A/JAP/57- 
infected target cells. The class  I-restricted CTL clones  14-1,  14-7,  14-13, and 
A4 failed to lyse A20-1.11 cells treated with UV-inactivated virus, a result which 
is  consistent  with  previous  findings  (22,  32),  suggesting  that  class  I-restricted 
anti-influenza  CTL preferentially recognize target cells expressing newly syn- 
thesized viral polypeptides on their surface.  In contrast,  the class  II-restricted 
CTL clones G 1, U-5, U-12, and V-4 lysed target cells pulsed with UV-inactivated 
virus,  and  lysed them  with an efficiency comparable to that  of infected target 
cells.  Furthermore, this capacity of class II-restricted CTL to recognize inacti- 
vated virus-pulsed target cells was not due to a unique property of the A20-1.11 
lymphoma targets  since  two  I-E~-restricted  CTL  clones,  G1  and  U-12,  could 
efficiently  lyse  UV-inactivated  virus-pulsed  CA36.2.1  fibroblast  target  cells 
(Table  I,  Exp.  2).  The  CA36.2.1  line  is  an  L  cell  (H-2  ~)  line  displaying  the 
products of the E~ and E~ genes expressed by DNA-mediated gene transfer (25). 
As  observed  for A20-1.11  targets,  two  MHC  class  I  (H-2Kk)-restricted  CTL 
clones, 35-6 and  36-1,  lysed infected L  cell transfectant targets but not inacti- 
vated  virus-pulsed  targets.  This  capacity of MHC  class  II-restricted  CTL  to 
recognize Ia  + target cells treated with noninfectious virions did not appear to be 
solely a property of a selected panel of cloned CTL; similar results were obtained 
with  heterogeneous populations of immune effectors generated by in  vivo im- 
munization  with  infectious A/JAP/57  virus followed by in  vitro restimulation 
and  short  term  in  vitro  culture  of  immune  sp]enocytes  with  virus-infected 
syngeneic splenocyte stimulators  (Morrison,  L.  A.,  et al.,  manuscript  in prepa- 
ration). 
The capacity of noninfectious virus to sensitize the Ia-expressing target cells 
for class II-restricted CTL recognition was dependent on the dose of virus used 
to  pulse  the  targets.  As  shown  in  Table  II,  treatment  of the  Ia  +  CA36.2.1 
transfectant with increasing amounts (HAU) of inactivated virions resulted in a 
greater target cell vulnerability to lysis. Indeed, efficient target cell sensitization 
routinely occurred with  10  HAU  of UV-inactivated  virus and  in some experi- 
ments  (Table  II,  Exp.  2),  iysis  was  detected  with  as  little as  0.1-1.0  HAU  of 908  VIRUS  RECOGNITION  BY  K/D  AND  I  REGION-RESTRICTED T  CELLS 
TABLE  III 
Effect of Inhibition of Protein Synthesis on Sensitization of 
Target Cells 
Percent specific 5|Cr-release from CA36.2.1 
targets*  with or without emetine 
Clone  E/T ratio  Uninfected  UV-A/JAP*  A/JAP in- 
pulsed  fected 
-|  +  --  +  --  + 
35-6  2:1  11  0  2  1  20  3 
8:1  3  l  6  4  44  10 
36-1  2:1  1  0  0  0  12  0 
8:1  2  1  0  !  32  2 
G1  2:1  1  0  15  16  10  12 
8:1  4  3  32  33  23  27 
U-12  2:1  1  0  15  16  10  12 
8:1  2  1  42  37  31  30 
D8  2:1  1  1  12  13  9  15 
8:1  4  6  23  25  18  29 
* As in  Table  I.  Spontaneous 5tCr-release  from all  target  groups was 
_<16% over an assay time of 4 h. 
* UV light-inactivated A/JAP/57 virus (1,000  HAU/5 ×  105 cells) was 
used to pulse the target cells. 
0 Infection and 5~Cr-labeling of target cells was carried out in the absence 
(-) or presence  (+) of 10  -5 M emetine-HCI.  The assay was carried out 
without emetine. 
I As in Table I. 
noninfectious  virus.  Target  cells  could  not be  sensitized  for class  I-restricted, 
CTL-mediated  lysis with even 3,000 HAU  of inactivated virus. 
Because  the  H-2I-restricted  CTL  could  recognize  target  cells  treated  with 
either  infectious  or noninfectious  virus,  it  was likely  that  de novo  viral  protein 
synthesis was not required  to sensitize target cells for recognition by these class 
II-restricted CTL. To establish this point we examined the effect of the protein 
synthesis inhibitor emetine on the capacity of infectious virus to sensitize target 
cells for class I- and class II-restricted  CTL  recognition.  Emetine  at a  concen- 
tration of ! 0 -~ M  completely inhibited nascent protein synthesis in Ia  + CA36.2.1 
targets  (as  measured  by  [aSS]methionine  incorporation).  This  concentration, 
however,  also dramatically  inhibited  CTL  function  when the ~Cr-release  assay 
was carried  out in the presence  of emetine.  Because  emetine  is an  irreversible 
inhibitor  of protein  synthesis  (33),  exposure  of the CTL  clones to emetine  was 
obviated  by  pretreating  the  L  cell  transfectant  targets  with  the  drug  during 
incubation with infectious or inactivated virus (see Materials and Methods).  Using 
this protocol, we observed that the H-2KLrestricted  CTL  clones 35-6 and 36-1 
lysed infected CA36.2.1  cells, but not infected target cells treated with emetine 
at the initiation of infection (Table III). Infected target cells treated with emetine 
after the onset of viral protein synthesis (4-6 h  after infection) were susceptible MORR1SON  ET  AL. 
TABLE IV 
Target Cell Sensitization by Purified Influenza Hemagglutinin 
909 
Clone  E/T ratio 
Percent specific 5~Cr-release from CA36.2.1  targets* 
B/Lee  UV-A/JAP*  HA  A]JAP 
infected  pulsed  pulsed  infected 
35-6  2: l  20  3  3  21 
8:1  7  9  9  39 
36-1  2:1  0  1  1  20 
8:1  2  2  2  43 
GI  2:1  2  31  23  24 
8:1  11  52  43  47 
U-12  2:1  0  28  22  32 
8:1  2  42  38  47 
* As in Table 1. Spontaneous 51Cr-release from all target groups was <_17%. 
~: 30  HAU  of purified,  UV light-inactivated A/JAP/57  virus, or isolated HA 
protein (80 #g/ml) were used to treat 5 x  10  s target cells. 
As in Table I. 
to  lysis  by class  I-restricted CTL  (data  not shown).  In contrast,  the class  II- 
restricted CTL clones G 1,  U-12, and D8 efficiently lysed L cell targets treated 
with either infectious or UV-inactivated virus preparations regardless of emetine 
pretreatment. These results indicated that nascent viral protein synthesis during 
viral  infection is  required to sensitize target cells for class  I-restricted, CTL- 
mediated cytolysis, but not for lysis by class II-restricted CTL. In this connection 
it should be noted that the infectious A/JAP/57 virus inoculum used to infect 
the target cells contained ~300 HAU of virion particles. As shown in Table II 
there is sufficient viral antigen in such a preparation to account for target cell 
sensitization by the input virions without de novo viral protein synthesis. 
The demonstration of target cell sensitization with intact, noninfectious virions 
for H-2I  region-restricted CTL recognition raised the possibility that isolated 
viral polypeptides might also render target cells susceptible to lysis. CTL were 
therefore examined for their capacity to recognize Ia  ÷ target cells treated with 
purified A/JAP/57 HA (Table IV). Two class II-restricted CTL clones, G1 and 
U-12, did indeed iyse target cells treated with isolated HA; these cells were lysed 
to a degree comparable to target cells treated with UV-inactivated or infectious 
A/JAP/57  virus.  Other influenza-specific, H-2I  region-restricted CTL  clones 
such as D8 (Table II) lysed target cells exposed to intact inactivated virions but 
not cells treated  with  purified  HA  (Morrison,  L.,  unpublished observations). 
These clones appear to be directed to virion polypeptides other than the HA 
(e.g., nucleocapsid protein). Also included in the analysis in Table IV were two 
MHC  class  I-restricted CTL  clones,  35-6  and  36-1,  that  are  HA-specific as 
defined by their recognition of L  cell targets displaying the A/JAP/57  HA by 
DNA-mediated gene transfer (34).  Once again,  these  HA-specific, class  I-re- 
stricted CTL failed to lyse purified HA- or inactivated virus-pulsed target cells 
but did recognize A]JAP/57-infected cells expressing the newly synthesized HA 
polypeptide.  Furthermore, as observed for inactivated virus-treated cells, the 910  VIRUS  RECOGNITION  BY  K/D  AND  1  REGION-RESTRICTED  T  CELLS 
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FIGURE  1.  Comparison  of  the  efficiency  of  target  cell  sensitization  by  UV-inactivated 
A/JAP/57 virus and purified A/JAP/57 HA. Clone G1 was tested for cytolytic activity against 
CA36,2.1  target cells pulsed with titrated amounts of purified, inactivated virions (©), or HA 
protein (0).  1 ×  104 CA36.2.1  targets were added per well; ratio of clones to targets is 4:1. In 
A, equivalent amounts of hemagglutinating activity are compared. These results are presented 
in terms of total protein content of the two preparations in B: 300 HAU of inactivated virions 
is equivalent to  1.3 ug protein;  300  HAU  of purified  HA  is equivalent to  8.1  ug protein. 
Percent  lysis  of target cells infected  with  300  HAU  infectious A/JAP]57  virus (m),  or of 
uninfected target cells (D) is indicated. Clone GI was used 5 d after routine subculture. Assay 
time was 6 h. Values are the means of quadruplicate wells, and SEM, always <5%, are omitted 
for clarity. 
capacity of purified HA to render target cells susceptible to lysis by H-2I region- 
restricted CTL was directly dependent on the amount of HA used to pulse the 
target cells (Fig.  1 a). Sensitization with purified HA, however, was less efficient 
than sensitization  with intact,  inactivated virions when activity per microgram 
protein was determined (Fig.  1 b). 
Recognition of soluble protein antigens by MHC  class  II-restricted Th  has 
been well documented (5,  35-41).  The lysosomotropic agent chloroquine has 
been reported to have an inhibitory effect on soluble protein antigen presentation 
for Th  recognition  (5,  42-45).  In  view  of the  several  functional  similarities 
between MHC  class  II-restricted CTL  and  Th,  and  the capacity of class  II- 
restricted CTL to recognize Ia  + target cells exposed to noninfectious virions or 
isolated HA in a manner analogous to presentation of protein antigens for H-2I 
region-restricted Th  recognition,  it  was  of interest to  examine the effect of 
cbloroquine on  target cell sensitization by noninfectious virus.  In preliminary 
studies  we  have  observed  that  chloroquine  in  concentrations  10 -5  M  in  the 
cytotoxicity assay directly inhibits the ability of class  I- and class  II-restricted 
CTL to lyse target cells already expressing viral proteins. This agent also retards 
early events in influenza virus replication (46).  To circumvent these problems, a 
two step protocol was devised using a chloroquine concentration of 5 ×  10 -5 M 
during the initial  target cell interaction with virus,  fo}lowed by a  lower (CTL 
noninhibitory) chloroquine concentration (5 ×  10 -6  M) maintained throughout 
the period of the cytotoxicity assay. As shown in Table V, the ability of class [I- 
restricted CTL to recognize target cells pulsed with UV-inactivated A/JAP/57 
virus or purified HA polypeptide is completely abolished by treatment of the 
target cells with chloroquine. Chloroquine treatment did not inhibit or diminish 
the level of expression of Ia molecules on the surfaces of the target cells during 
the 4-6-h period of the assay, as determined by cytofluorometric analysis (not 
shown). In control experiments where 51Cr-labeled A20-1.11  cells were exposed 
to  the  inactivated virus  preparation,  then  incubated at  37°C  for 4  h  before MORR1SON  ET  AL.  911 
TABLE V 
Effect of Chloroquine on Target Cell Sensitization by Inactivated Virus and 
Purified HA Protein 
Percent specific ~Cr-release from A20-1.11 targets* 
Clone  UV-JAP +  HA +  Uninfected  UV-JAP*  chloroquine0  HA  cbloroquine 
14-1  2  ~  17  10  1  0 
14-7  0  3  2  0  0 
G1  2  54  2  43  1 
U-12  0  45  0  38  0 
* As in Table I. Spontaneous 51Cr_release  from all target groups was < 10%. E/T 
ratio is 5:1. 
As in Table IV. 
0 Target cells were exposed to antigen in the absence or presence of 5 ×  10  -5 
M chloroquine. Chloroquine was then maintained at a lower concentration (5 
× 10  -6 M) throughout the course of the assay as described (see Materials and 
Methods). 
As in Table I. 
chloroquine treatment and use as targets in the cytotoxicity assay, no inhibitory 
effect of chioroquine  on  the  magnitude  of target  cell  lysis  was  observed  (not 
shown). Thus, recognition of these "soluble" influenza viral constituents by these 
MHC  class  II-restricted CTL appear  to be chloroquine sensitive in  a  manner 
analogous to Th recognition of soluble protein antigens. 
The ability of H-2I region-restricted CTL to recognize target cells exposed 
to infectious virus in the absence of de  novo  viral protein synthesis (Table III) 
implies that virions in an infectious virus inoculum can sensitize target cells for 
recognition by these CTL in a manner analogous to sensitization by noninfectious 
virion preparations. In light of the profound inhibitory effect of chloroquine on 
target cell sensitization using noninfectious virus, we next examined the capacity 
of infectious A/JAP/57  virus to render target cells susceptible to lysis by H-2I 
region-restricted CTL in the presence of chloroquine. The results of this analysis 
are shown in Table VI. Both the class II-restricted, HA-specific CTL clones G1 
and U-12, and the class I-restricted, HA-specific CTL clones 14-1 and 14-7 (26), 
efficiently lysed control infected A20-1.1 1 targets maintained in the absence of 
chloroquine. Importantly, chloroquine had no effect on target ceil sensitization 
for class I-restricted CTL recognition; clones 14-1 and 14-7 lysed the A/JAP/57- 
infected, chloroquine-treated cells as efficiently as the control infected cells. High 
levels  of  the  influenza  HA  were  detectable  by  hemadsorption  on  infected, 
chloroquine-treated target  cells  by  4-6  h  after infection at  37°C.  In  marked 
contrast, chloroquine completely abolished sensitization of the target cell popu- 
lation for recognition by the class II-restricted CTL clones G1 and U-12. Again, 
in control experiments where infected target ceils were first incubated for 4 h at 
37 °  and  then  exposed  to  the  chloroquine  regimen,  no  inhibitory  effect  of 
chloroquine on sensitization  was observed for either H-2K/D or H-2I region- 
restricted CTL clones. Therefore these chloroquine-treated, infected target cells 
that expressed high levels of the viral HA molecule on their surfaces as detected 
by hemadsorption (HA levels indistinguishable from those expressed by control 
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TABLE  VI 
Effect of Chloroquine on Target Cell Sensitization by Infectious Virus 
Clone 
Percent specific 5JCr-release from A20-1.11 targets* 
Uninfected  A/JAP  A/JAP infected 
infected  + chloroquine* 
14-1  4  j  64  66 
14-7  2  66  62 
Gl  4  68  14 
U-12  2  67  7 
* As in  Table  I.  Spontaneous 5~Cr-release  from all  target  groups was 
<10%. E/T ratio is 5:1. 
* Target ceils were exposed to infectious A/JAP/57 virus (10-50 infec- 
tious units per cell) in the absence  or presence  of 5 x  10  -9 M chloroquine. 
Chloroquine was then maintained at a lower concentration (5 x  10 -6 M) 
throughout  the  course  of the assay as  described (see  Materials  and 
Methods). 
0 As in Table I. 
however, failed to serve as adequate targets for HA-specific, class  II-restricted 
CTL.  This finding suggests that the presentation of the antigenic moieties on 
virus-infected cells to H-2I region-restricted CTL is also chloroquine-sensitive. 
One interpretation of the results presented in Tables V and VI is that the H- 
21  region-restricted  CTL  efficiently recognize  only  exogenously introduced 
influenza viral  constituents expressed on the target cells.  In  the case of virus 
infected cells, virions in the infectious inoculum would serve as the source of the 
viral antigens. According to this interpretation, the H2I region-restricted CTL 
would not recognize newly synthesized viral polypeptides expressed on the virus- 
infected cell. The failure of HA-specific, class  II-restricted CTL to recognize 
the HA on chloroquine-treated, infected target cells would appear to be consist- 
ent  with  this  interpretation.  Alternatively,  chloroquine  could  be  selectively 
inhibiting the presentation of newly synthesized viral polypeptides on the infected 
target cells. An approach to distinguish between these possibilities was to permit 
synthesis and expression of the relevant viral polypeptide in the target cell in the 
absence of chioroquine and without introduction of the viral antigen in the input 
virion preparation, since the latter antigen source could ultimately be presented 
by the target cells.  To achieve this end we introduced the gene encoding the 
influenza A/JAP/57  HA  into  A20-1.11  target  cells  using a  recombinant VV 
expression vector and tested the capacity of these cells to be recognized by HA- 
specific, class  I- and class  II-restricted CTL clones (Table VII).  None of the 
clones lysed uninfected target cells or target cells infected with the parent VV. 
All of the CTL clones efficiently lysed A/JAP/57-infected target cells. Strikingly, 
only the class  I-restricted, HA-specific CTL clones  14-1 and  14-7  recognized 
and  destroyed cells  infected with  the  VV/HA.  The  class  II-restricted,  HA- 
specific CTL clones G1 and U-12 showed no capacity to recognize the influenza 
HA introduced and displayed on the cell surface via the recombinant vaccinia 
expression  vector.  As  reported previously (23),  target cells infected with  the 
recombinant VV were found to express high levels of cell surface A/JAP/57 HA 
which  were comparable  to  levels  displayed  on  influenza  virus-infected cells. 
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TABLE  VII 
CTL Response to Target Cells Infected with Purified VV/HA 
Recombinant  Virus 
Percent specific 5'Cr-release from A20-1.11  targets* 
Clone  Un-  Vaccinia  VV/HA*  A/JAP 
infected  infected  infected  infected 
14-1  20  1  49  69 
14-7  0  0  77  68 
G1  3  3  4  68 
U-12  1  1  0  69 
* As in  Table  I.  Clones were  examined  for cytolytic activity 4  d  after 
routine subculturing. Spontaneous ~Cr-release from all target groups 
was <12%. E/T ratio is 5:1. 
* Indicates target cells infected with  VV/HA.  25  ul  of highly purified 
VV/HA (~101° PFU/ml) was used for infection. 
As in Table I. 
not readily attributable to quantitative differences in HA expression on vaccinia- 
and influenza-infected targets.  Furthermore, VV infection itself did not signifi- 
cantly  inhibit  presentation  to  MHC  class  II-restricted  CTL,  for  concomitant 
exposure of target cells to parental VV and inactivated A/JAP/57 virions resulted 
in strong sensitization for class II-restricted lysis (data not shown). These studies 
used a highly purified preparation of the HA recombinant VV which contained 
no detectable influenza HA in the virion preparation. In companion studies (not 
shown) crude vaccinia preparations  consisting of homogenates of infected cell 
cultures,  which  contained  the  influenza  HA  gene  product,  readily  sensitized 
target cells for class II-restricted CTL recognition. 
Discussion 
This report examines viral antigen presentation for target cell recognition by 
influenza virus-specific CTL restricted by either class I (H-2K/D region) or class 
II (H-2I  region) MHC gene products. For this analysis we used a panel of well- 
characterized  cloned CTL of defined viral  specificity and  H-2  restriction.  We 
have observed clear-cut differences between MHC class I- and class II-restricted 
CTL in the antigen presentation requirements for target cell sensitization and 
recognition. 
The observation that class II-restricted CTL could efficiently lyse target cells 
treated with noninfectious influenza virion or purified HA preparations provided 
the initial evidence for a divergence between MHC class I- and class II-restricted 
CTL in viral antigen recognition. This distinction was reinforced by the finding 
that inhibition of nascent viral synthesis in infected target cells abolished target 
cell recognition by class I-restricted CTL but did not affect target cell recognition 
by class II-restricted CTL. Thus, while H-2K/D region-restricted CTL prefer- 
entially recognize target cells displaying viral polypeptides as a result of de novo 
viral  protein  synthesis in  virus-infected cells,  H-2I  region-restricted  antiviral 
CTL  could,  like  most  H-2I  region-restricted  T  lymphocytes (47,  48),  also 
recognize and  respond  to  the  soluble  form of antigens displayed by antigen- 
pulsed  presenting  cells.  These  initial  findings suggested,  then,  that  class  II- 914  VIRUS  RECOGNITION  BY  K/D  AND  I  REGION-RESTRICTED  T  CELLS 
restricted CTL were capable of recognizing either newly synthesized viral poly- 
peptides,  or  exogenous  viral  polypeptides  derived  from  the  input  infectious 
virions and subsequently, displayed on the target cell surface. 
A crucial and unexpected result that did not support this viewpoint emerged 
when the effect of chloroquine on class I- and class II-restricted CTL recognition 
was examined.  This  lysosomotropic amine  has  been  shown  to  inhibit  antigen 
presentation to MHC class II-restricted Th cells (5, 42-45). Our results parallel 
these observations in that recognition of target cells pulsed with inactivated virus 
or purified  HA by class II-restricted,  HA-specific CTL clones was completely 
abolished by chloroquine treatment.  Surprisingly, recognition of infected target 
cells  by these  class  II-restricted  CTL  clones  was  also  dramatically  inhibited. 
Chloroquine treatment, however, had no effect on the expression or recognition 
of newly synthesized cell surface HA by HA-specific, class I-restricted CTL. The 
concentration  of cbloroquine used in the assay (5 x  10  -6 M) did not appear to 
inhibit  influenza  HA synthesis or migration  of the  nascent  polypeptide to the 
cell surface, since abundant HA was readily detectable on the infected cell surface 
by  4  h  after  infection.  These  results  raised  the  possibility  that  the  class  II- 
restricted,  HA-specific CTL  recognized  only target  cells sensitized  by exoge- 
nously introduced HA molecules. 
Since the mechanism  by which chloroquine inhibits  MHC class II-restricted 
T  lymphocyte recognition  is  not precisely defined,  and  since this  agent  could 
have  multiple  effects on  target  cell  physiology, the  results of the  studies  with 
chloroquine could be open to other interpretations.  As an alternative approach 
to the  issue of exogenous antigen  and  class II-restricted  CTL  recognition  we 
employed a recombinant vaccinia virus expression vector to sensitize target cells. 
In  these experiments,  in  which the HA gene but not the  HA polypeptide was 
introduced  into  the  target  cell  by the  vaccinia  vector,  newly synthesized  HA 
protein was demonstrable on the infected cell surface, and these HA-expressing 
target cells were readily lysed by class I-restricted CTL (49). These same targets 
were not, however, recognized by HA-specific, class II-restricted CTL clones. 
Taken together, the findings reported here raise the possibility that important 
differences exist in viral antigen  presentation and recognition by MHC class I- 
and class II-restricted T  lymphocytes. Although this report has focused for the 
most part on CTL directed to the influenza HA, comparable differences appear 
to be evident for class I- and class II-restricted T  lymphocytes directed against 
influenza  virion  polypeptides  (Morrison,  L.,  unpublished  observations).  More 
importantly,  these results are in keeping with our previous in vivo observations 
in  the  mouse  where  differences  in  in  vivo  CTL  responses  to  infectious  and 
noninfectious  virus  preparations  were  noted  (22).  As  mentioned  above,  the 
present  data  suggest  that  HA-specific,  class  II-restricted  CTL  preferentially 
recognize target cells displaying exogenously introduced HA. This HA could be 
in an  altered  or processed form on  the cell surface as a  result of intracellular 
trafficking  through  an  acid  endocytic compartment.  At  present,  we  have  no 
direct biochemical evidence for a processing event.  Presentation  of the HA on 
the cell surface as an intact molecule is equally possible. Class I-restricted,  HA- 
specific CTL, on the other hand, appear to preferentially recognize HA displayed 
on the target cell surface as a  result of de  novo  polypeptide synthesis. Whether MORRISON  ET  AL.  915 
this is the intact native HA expressed as an integral membrane constituent or a 
truncated portion of the molecule is not as yet known and is under investigation. 
Studies of class I-restricted CTL recognition in several other antigen systems 
appear  to  differ from  those  reported  here.  These  include observations  with 
soluble hapten-protein conjugates (50), the nonstructural SV40 virus T  antigen 
(51,  52),  a  genetically engineered chimeric HA  molecule (53),  as well as  the 
internal  influenza  virus  nucleoprotein  (NP)  (54,  55),  and  polymerase  gene 
products (56). In these systems either exogenously introduced antigens (50, 53) 
or nonstructural and internal viral polypeptides can serve as target antigens for 
H-2K/D region-restricted CTL. On the basis of their studies of class I-restricted 
CTL recognition of the NP antigen, Townsend et al. (54,  55) have speculated 
that  MHC class  I-restricted CTL,  like class  II-restricted T  lymphocytes, may 
primarily recognize degraded or fragmented forms of viral antigens displayed 
on  the  target  cell  surface.  The  observations  reported  here  are  not  entirely 
consistent with such a proposal.  Notably, the lysosomotropic agent chloroquine 
fails to  inhibit  target  cell  sensitization  for class  I-restricted CTL  recognition 
under conditions where class II-restricted CTL recognition is completely abol- 
ished. Likewise, isolated influenza HA fails to sensitize target cells for recognition 
by  HA-specific, class  I-restricted CTL,  though  exposure to  it  readily makes 
target  cells  vulnerable  to  class  II-restricted  CTL  recognition and  lysis.  This 
sensitization  step  for  class  II-restricted  CTL  recognition  is  also  chloroquine 
inhibitable.  In  the  least,  our  results  suggest  that  if class  I-restricted  CTL 
recognize forms of antigen other than the native molecule, presentation for class 
I-restricted CTL recognition occurs by a  mechanism distinctly different from 
that  required  for  class  II-restricted  CTL.  In  this  connection,  it  should  be 
emphasized that the intrinsic properties of disparate molecules like the integral 
membrane HA glycoprotein and soluble, predominantly intracellular nonglyco- 
sylated NP protein may play a key role in dictating the form of  antigen recognized 
by CTL. 
An alternate, highly speculative hypothesis, which could account for our results 
and those of others (50-55, 57), is that class II-restricted antiviral CTL recognize 
predominantly antigenic epitopes exposed during (or which potentially survive) 
intracellular processing events associated with endocytosis of input viral polypep- 
tides prior to their reexpression on the cell surface. Indirect evidence supporting 
this view has come from studies on H-2I region-restricted T  lymphocyte recog- 
nition of soluble protein and  viral antigens (30,  58,  59).  In contrast,  class  I- 
restricted antiviral CTL would be preferentially directed against antigenic epi- 
topes  displayed on  viral  polypeptides in  their native conformation. Thus  the 
apparent  requirement for nascent HA protein  synthesis in  the recognition of 
target cells by HA-specific, class I-restricted CTL reflects the presence of the 
target HA epitopes for these CTL only on the newly synthesized and expressed 
native HA molecule. The failure of exogenous HA to sensitize target cells for 
recognition by these class I-restricted CTL could be explained by the loss of the 
relevant HA epitopes during trafficking of the exogenously introduced protein 
through an endocytic compartment. The possible importance of antigen confor- 
mation in class  I-restricted CTL recognition has been suggested by studies of 
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Furthermore, according to this hypothesis certain antigens might sensitize target 
cells directly without de novo protein synthesis if the epitopes on these antigens 
could survive transit  through  an  endocytic compartment  and  retain  a  confor- 
mation necessary for H-2K/D region-restricted CTL recognition upon reemer- 
gence at the cell surface. This model can also account for the results of Tevethia 
et al.  (51) and Gooding and  O'Conneil  (52),  who show class I-restricted  CTL 
recognition of cells transfected with fragments of the gene encoding the SV40 
T  antigen,  and  more  recent  results  of Townsend  et  al.  (55)  using  NP  gene 
fragments, since these newly synthesized truncated antigen molecules might still 
retain appropriate  conformational epitopes. Similarly, this paradigm  affords an 
explanation  for the finding that Sendal virus virions with cleaved, active fusion 
proteins can directly sensitize target cells for class I-restricted CTL recognition 
without  de  novo  viral  protein  synthesis,  while  Sendal  virus  without  an  active 
fusion protein fails to sensitize target cells (57). In this instance, direct fusion of 
the Sendal virion surface polypeptide into the target cell cytoplasmic membrane 
would  maintain  the  conformational  stability  of the  target  epitopes,  whereas 
endocytosis of the  fusion-negative  virions  would result  in  loss of the  relevant 
target epitopes before reemergence of viral antigens on the cell surface. Exper- 
iments are now in progress to further examine this hypothesis. 
Perhaps  the  most  important  issue  raised  by the  observations  in  this  report 
concerns the function of MHC class II-restricted antiviral CTL in recovery from 
viral  infection.  The  failure  of the  H-2I  region-restricted  CTL  to  recognize 
chloroquine-treated,  infected target  cells, or target  cells infected with the  HA 
recombinant  VV, suggests that these CTL do not recognize viral polypeptides 
expressed on  the  cell  surface as a  direct result  of viral  infection.  Preliminary 
analysis of the in vivo effector activity of the HA-specific CTL clone G 1, however, 
indicates  that  this  clone  can  efficiently promote  recovery of lethally  infected 
recipients  after adoptive in  vivo transfer  (Lukacher,  A.,  unpublished  observa- 
tions). Furthermore,  this clone can reduce pulmonary influenza virus titer with 
an efficiency and time course comparable to class I-restricted CTI_.. Thus, these 
class II-restricted CTL likely play a positive role in viral clearance and recovery 
from viral  infection.  The  mechanism  through  which  these cells exert their  in 
vivo antiviral  effect and  the  target  cells for  these  CTL  in  vivo remain  to  be 
elucidated. 
In conclusion,  in  this  report we have analyzed a  panel of MHC class I- and 
class  II-restricted,  influenza-specific  CTL  which  appear  to  exhibit  distinctly 
different requirements for viral antigen presentation  in target cell recognition. 
These differences may reflect differences in the structure of the antigen receptors 
used by class I- and  II-restricted  CTL,  or may reflect intrinsic  differences in 
the structure of MHC class I and  II molecules and in the range of interaction 
between  viral  antigens  and  these  two  classes  of  MHC  molecules.  Since  the 
structure  and organization  of the antigen  receptors on these CTL subsets can 
now be analyzed at the molecular level it should be possible to relate  antigen 
recognition to antigen receptor structure. An understanding of the basis for the 
difference in antigen presentation requirements for recognition between class I- 
and class II-restricted CTL should elucidate requirements for induction of these MORRISON  ET  AL.  917 
two CTL subsets in vivo. This would have obvious implications for future viral 
vaccine design. 
Summary 
We have examined requirements for antigen presentation to a panel of MHC 
class I- and class lI-restricted, influenza virus-specific CTL clones by controlling 
the form  of virus  presented on  the  target  cell surface.  Both  H-2K/D-  and  I 
region-restricted CTL  recognize target cells exposed to  infectious virus,  but 
only the I region-restricted clones efficiently lysed histocompatible target cells 
pulsed with inactivated virus preparations. The isolated influenza hemagglutinin 
(HA) polypeptide also could sensitize  target cells for recognition by class  II- 
restricted,  HA-specific CTL,  but  not  by class  I-restricted,  HA-specific CTL. 
Inhibition of nascent viral protein synthesis abrogated the ability of target cells 
to present viral antigen relevant for class I-restricted CTL recognition. Signifi- 
cantly, presentation for class II-restricted recognition was unaffected in target 
cells  exposed  to  preparations  of either  inactivated  or  infectious  virus.  This 
differential sensitivity suggested that these H-2I region-restricted  CTL recog- 
nized viral polypeptides derived from the exogenously introduced virions, rather 
than viral po/ypeptides newly synthesized in the infected cell.  In support of this 
contention, treatment of the target cells with the lysosomotropic agent chloro- 
quine abolished recognition of infected target cells by class II-restricted CTL 
without diminishing class  I-restricted recognition of infected target cells.  Fur- 
thermore, when the influenza HA gene was introduced into target cells without 
exogenous HA polypeptide, the target cells that expressed the newly synthesized 
protein  product  of the HA  gene were recognized only by H-2K/D-restricted 
CTL. These observations suggest that important differences may exist in require- 
ments for antigen  presentation  between  H-2K/D  and  H-2I  region-restricted 
CTL. These differences may reflect the nature of the antigenic epitopes recog- 
nized by these two CTL subsets. 
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